chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Soreness came back: Left Arm from Elbow to shoulder; vaccination site pain; Palpitation; Pain Left Breast; Could not lift arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PALPITATIONS (Palpitation), BREAST PAIN (Pain Left Breast), MOBILITY DECREASED (Could not lift arm), PAIN (Soreness came back: Left Arm from Elbow to shoulder) and VACCINATION SITE PAIN (vaccination site pain) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PALPITATIONS (Palpitation), BREAST PAIN (Pain Left Breast), MOBILITY DECREASED (Could not lift arm) and VACCINATION SITE PAIN (vaccination site pain). On 11-Mar-2021, the patient experienced PAIN (Soreness came back: Left Arm from Elbow to shoulder). On 19-Feb-2021, BREAST PAIN (Pain Left Breast), MOBILITY DECREASED (Could not lift arm) and VACCINATION SITE PAIN (vaccination site pain) had resolved. On 02-Mar-2021, PALPITATIONS (Palpitation) had resolved. At the time of the report, PAIN (Soreness came back: Left Arm from Elbow to shoulder) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided.  Treatment  include warm shower.
Edema noted to (L) deltoid no redness noted. Instructed pt to apply cool and warm compresses.
swelling 3 weeks after the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling 3 weeks after the shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling 3 weeks after the shot). At the time of the report, VACCINATION SITE SWELLING (swelling 3 weeks after the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information was provided.
blood "gushing" internally; heart began to pump at a rate well above normal; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0182, Expiry date: unknown), via an unspecified route of administration, administered in Arm Left on 12May2021 14:30 as dose 2, single for covid-19 immunisation administered at Pharmacy or Drug Store. The patient medical history and concomitant medications were not reported. The historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ER8736, Expiry date: unknown), via an unspecified route of administration, administered in Arm Left on 21Apr2021 14:30 as dose 1, single for covid-19 immunisation. Other vaccine in four weeks was none. Covid was not tested prior to and post vaccination. No Known allergies. On 06Jun2021 08:00 PM, the patient reported, she was walking to a convenience store in a hurry. She picked up her pace and her heart began to pump at a rate well above normal. As a former runner, she would say it felt like she was running fast. She slowed down, her heart did not. She could feel her heart pumping blood like crazy, even after sitting. It took almost an hour of non-motion before her heart/pulse rate went back to normal. This has happened several times since though she had slowed down considerably and not "let" her heart/pulse rate increase beyond a certain level. Subsequent events feel like an instant increase of heart/pulse rate. Not running levels but, sudden fast pumping and she could feel her blood "gushing" internally. Even just moving at a leisurely pace. Patient did not received treatment for events. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
At time of vaccination no adverse events where noted. Per patient wife, we were informed on 12/30/2021 at around 11am patient had experienced a heart attack in the early morning of 12/28/2021 and passed away around 3am. Wife was directed by providers at the hospital to contact us asked that we report event to VAERS due to concern with timing.
Right eyelid felt funny, like it was swelling but it visually looked ok.  About 30 min after I left the vaccination site I notice my face (cheek area)  seemed to feel numb and swollen.   This all went away after a few hours.
Admin on 9/27/16 in left upper arm. Pt. complains of ongoing pain in joint (shoulder) area. No bruising, no lumps at injection site.
In August 2021, my period became very very heavy which is not normal for me. Then in March 2022 I developed a blot clot in my right lower leg that broke off and went up into both of my lungs causing bilateral pulmonary embolisms.
redness and swelling from the shoulder to the elbow on inner and outer arm; Areas with hard lumps; severe tenderness to the touch
Temp to 104.9 about 72 hrs after vaccine with fever. Pat became pale, limp, unresponsive with eyes rolling back. Lasted only few seconds. After limpness, woke up, said mama and fell asleep. No ER visit. Followed up with me day after the event 7/17.
Within 7-10 minutes after receiving his second dose of COVID-19, patient started complaining of rapid heart rate and palpitations which then progressed into dizziness and lightheadedness during his observation period. Patient was subsequently moved to a room and further evaluated including vital signs and 12 lead EKG. It was determined that patient is currently undergoing workup for possible cardiac issue, was recently started on Nitroglycerin yesterday and has a tentative angiogram scheduled Monday 3/1/21. After lying down during the evaluation patient's dizziness began to worsen. Talked with patient and spouse and recommended transport to the hospital for further evaluation.
The patient received SHINGRIX. Patient just had soreness and redness at injection site. 5 days later 6 inch rash developed and increased itchiness.
Fever 103.8 starting ~ 24 hrs post vaccine with arthralgias myalgias nausea vomiting.
This case was reported by a pharmacist via call center representative and described the occurrence of bruising of arm in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced bruising of arm, local swelling, erythema urticarial and nodule. On an unknown date, the outcome of the bruising of arm, local swelling, erythema urticarial and nodule were unknown. It was unknown if the reporter considered the bruising of arm, local swelling, erythema urticarial and nodule to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient received the SHINGRIX vaccine approximately a month ago and experienced a raised bruised area several inches below the injection site, whelps on the bruised area as well as around the bruise, and a nodule in her eye. The pharmacist indicated that there was a little bit of redness where the whelps were on her arm at the time of reporting. The pharmacist did not provide the consent to follow up. The pharmacist was unable to provide additional information.
Got her vaccine, was at the hospital, and went to the ER for something else, informed them that she was having headaches, and had chest pain, fatigue and swelling in her feet.  She still has swelling in her feet.  She has a disorder and they don't know what she has and were not able to treat her for her symptoms.  Due to her celiac disease she cannot take a lot of medications or antibiotics, and has to be very careful about her medications.  She uses prayer, medication, drinks water and does not eat man made food and has to be very careful what she eats or takes in.    She has seen a cardiologist who told her she was fine, and also a pulmonologist and multiple ER visits that there is nothing wrong with her heart.   She feels that anybody with any type of processes should not get the vaccine.     She says she does not have a defined diagnosis to what she has.    She went to the ER for her psychosis, but mentioned she was having reactions to the vaccine while there.
Increasing swelling on left side of my left pectoral muscle.  No pain. No lumps.  Soft swelling about equivalent to tennis ball. Immediately after the shot, the area around the shot was sore for about 24 - 48 hours.  That has gone away.   No other pain or adverse effects. Have been exercising every day, including lifting weights.
She may have had a reaction to the J&J covid shot. her appendix ruptured and she went into surgery on4/11/21.  she went back to surgery on 4/16/21 and had two drainage tubes.  later it was discovered that she had E Coli
18 days after 2nd injection I developed headache, chills, and fever. Also had abdominal bloating and gas cramps. The headache and fever lasted 30 hours. Is it possible this is a reaction to the vaccine? Had no other symptoms, but had had headache and achiness  for 2 days right after vaccine.
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. The patients medical history and current condition are not reported. IT was reported that on 04-AUG-2014 the patient ws vaccinated with expired M-M-R II of unknown strength, dose and frequency (lot # 0287AE and Expiry date 01-FEB-2014). Also reported that the M-M-R II did not have any previous temperature excursions. No adverse events reported. There is no product quality complaint. The outcome of the event is unknown.  Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown demographics. On an unknown date an unspecified number of patients might have been vaccinated with improperly stored dose of VAQTA. Dose, lot and expiry date were unspecified. No adverse effects were reported. This is 3 of several cases from same reporter. Additional information has been requested.
Fever of 101.2, aches and pains throughout whole body, headache.  I feel like I have the flu, got hit by a truck
sore arm from vaccine; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program (060820).  A 64 year-old female patient received bnt162b2 (BNT162B2), administration date 26Oct2021 (Batch/Lot number: unknown) at the age of 64 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: IBRANCE taken for breast cancer, start date: 04Jun2021, stop date: 14Sep2021; FASLODEX. Vaccination history included: Bnt162b2 (Dose:1), for Covid-19 immunization; Bnt162b2 (Dose:2), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "sore arm from vaccine".  Additional Information: it was reported that patient received current dosing 100mg 1 tablet by mouth for 21 days, then off for 7 days. It started 04Jun2021 and hold on 14Sep2021. Faslodex injections.  Patient reported Ibrance still on hold due to vacation since 14Sep2021. Patient planned to restart ibrance 04Nov2021 reported usual ongoing tiredness since start of therapy. No ad-verse effects from medication hold. she did receive pfizer booster vaccine 26Oct2021 when she arrived home to . reports sore arm from vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After receiving my 3rd dose I felt very tired and all of a sudden I felt very hot. I started to sweat to the point people noticing. I looked very pale and sick. I went to the hospital to the emergency room and after 45 minutes the symptoms started to go away gradually. I received an ekg which came back negative, cardiac components- negative, routine lab work, a chest x-ray and everything came back normal.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 28-Jul-2021. On 01-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 01-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
a 30-something years old patient received an expired dose of VAQTA; This spontaneous report was received from a nurse practitioner referring to a 30-something years old patient of unknown gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.        On 17-SEP-2020, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (1 ml, lot # S021729, expiration date 20-AUG-2020, via intramuscular route) for prophylaxis (expired product administered). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: S021729; expirationdate: 20-AUG-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Extreme aches and soreness. Was cold even though house was very warm.  Had a hard time sleeping; breathing in short breaths.  Took Advil, and was able to sleep through the night.
An 82 year old male patient had bladder cancer diagnosed early 2002, which treated with OncoTice from a different physician.  The patient experienced subsequent, persistent haematuria, which was stopped twice in May 2002 after treatment.  His present physician diagnosed a Grade II carcinoma of the bladder, and he has had ongoing problems with hematuria, for which hyperbaric oxygen therapy was offered, but declined by the patient was "too painful".  A single instillation was given in April 2003, followed again by hematuria for 4-5 weeks.  After the hamaturia had stopped for 1-2 weeks, a second instillation was given on 06/04/2003. The patient experienced difficulty with urgency and incontinence, and has had hematuria during the week following the most recent instillation.  It is unknown if any further OncoTice has since been given.
Rash on left arm; Body aches; Fluctuating Fever; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on left arm), MYALGIA (Body aches), PYREXIA (Fluctuating Fever), HEADACHE (Headache) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A, and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Rash on left arm), MYALGIA (Body aches), PYREXIA (Fluctuating Fever), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, RASH (Rash on left arm), MYALGIA (Body aches), PYREXIA (Fluctuating Fever), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99-101.7 (abnormal) fluctuated from 99.0 to 101.7. and 99 (normal) back down again to 99 to normal 97-98 range..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided. treatment to the events not reported.   This case was linked to MOD-2021-023247 (Patient Link).
Patient continues to have ongoing RIGHT lateral deltoid pain limiting ROM, especially crossover, and affecting her sleep due to pain. Patient has tried icing, stretches, massage and topical essential oils. Now she has seen me in the clinic, more than 3 months post-vaccine.  She is referred to Physical Therapy and prescribed topical Voltaren gel for pain today.
This spontaneous report was received from a registered nurse and refers to a 5 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The stock of vaccine was received on 11-OCT-2016. On 29-DEC-2016, the patient was vaccinated with an improperly stored dose of PROQUAD, lot # M023931 with expiration date of 09-NOV-2017 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 49 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1705USA013888.
enlarged lymp nodes in left clavicle; A spontaneous report was received from a Consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events enlarged lymph nodes in her left clavicle.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, patient experienced enlarged lymph nodes in her left clavicle.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  On an unknown date the outcome of events, enlarged lymph nodes in her left clavicle was not reported.
shot area became very inflamed, hard lump formed;pt devel cough & exp lowered appetite;problem area is lower site on rt thigh, was determined to be DTAP inj site;
I received the shot, I sat there for twenty minutes. We left and I took my mom home and went home myself. I was fine, my dog broke his leash, I went up to a store and in the store I had a metal/tin can taste in my mouth. SO while in the store I took two Benadryl and the tin taste was still there but the swelling in my mouth was down. I took two more when I got home. In the next morning I had that tin taste in my mouth still, over a month. That metal taste in my mouth hasn't gone away. Every muscle in my body hurts. I also got a severe headache, like a pounding headache. The Monday following my vaccine, I called the DR because I literally had to sleep with the heating pad on my head and was taking medication as much as possible, Tylenol then Advil. I told the DR that my head hurt so bad that I could not think, then they called some medication in for a headaches, I cannot remember what it was. I told her I still had to go to work because I have my own business. I felt like crap and my muscles still ache. The only thing I have now is that my muscles ache, I am just so tired with low energy. So I went back to the DR and they ran bloodwork. The DRs have no answers for me because I am having a reaction but my tests come back fine to the shot but they told me not to get the 2nd dose due to my reactions.
Information has been received from a registered nurse concerning a female teenager, who in approximately September 2009 ("fall 2009") was vaccinated with a dose of 0.5 ml GARDASIL (lot #, injection site and route unspecified). When the patient was given GARDASIL, she had "a seizure with tonic clonic movements" and she "coded". They called 911 and she was revived and recovered "immediately after it happened". Therapy with GARDASIL was discontinued and not reintroduced. The nurse considered the "seizure with tonic clonic movements" to be immediately life-threatening. Reporter also stated that "this event has already been reported to the CDC and VAERS and it has been determined to be unrelated to GARDASIL." No further information is available.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed 6 to 10 lesions with no fever.
This spontaneous report as received from a nurse who is also the mother of the patient, refers to a 13 year old male patient with dust, grass, cat and CEFTIN allergy. Medical history was not reported. On approximately 16-AUG-2013 reported as "about 6 weeks ago", the patient was vaccinated with GARDASIL (dose, route and lot were not reported). Concomitant therapies included ALLERTEC, BENADRYL and an unspecified allergy shot (manufacturer unknown). On approximately 18-AUG-2013, about 48 hours after GARDASIL was administered, the patient developed huge, swollen lymph nodes on his left neck and clavicular area. The reporter stated that since the patient was administered GARDASIL in approximately August 2013, the patient had been very tired, weak and had developed a cold. The reporter stated that as of 27-SEP-2013, the swelling had reduced significantly; however, the patient still had 8 lymph nodes that were still swollen and palpable on his left side. The patient sought for medical attention. He went to the physician's office twice. On an unknown date, results of a complete metabolic panel that was performed were "fine". No treatment given for the events. The reporter stated that the patient has been getting unspecified allergy shots (manufacturer unknown) for four years and received an unspecified allergy shot about a week before GARDASIL was administered. Also reported that beginning on an unspecified date within 2 months prior GARDASIL administration, the frequency of the patient's allergy shots were increased to every two weeks. The patient's unspecified allergist had postponed all allergy shots at this time. At the time of the report, the outcome of the events was reported as recovering. Additional information has been requested.